109 related articles for article (PubMed ID: 16781761)
1. Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis.
Wang Y; Rice AP
Virology; 2006 Sep; 352(2):485-92. PubMed ID: 16781761
[TBL] [Abstract][Full Text] [Related]
2. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages.
Liou LY; Haaland RE; Herrmann CH; Rice AP
J Leukoc Biol; 2006 Feb; 79(2):388-96. PubMed ID: 16330531
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 infection and regulation of Tat function in macrophages.
Liou LY; Herrmann CH; Rice AP
Int J Biochem Cell Biol; 2004 Sep; 36(9):1767-75. PubMed ID: 15183343
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.
Wang J; Crawford K; Yuan M; Wang H; Gorry PR; Gabuzda D
J Infect Dis; 2002 Apr; 185(7):885-97. PubMed ID: 11920312
[TBL] [Abstract][Full Text] [Related]
5. Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages.
Song H; Nakayama EE; Shioda T
AIDS; 2006 Apr; 20(6):937-9. PubMed ID: 16549982
[TBL] [Abstract][Full Text] [Related]
6. Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.
Imai K; Asamitsu K; Victoriano AF; Cueno ME; Fujinaga K; Okamoto T
FEBS J; 2009 Dec; 276(23):7124-33. PubMed ID: 20064163
[TBL] [Abstract][Full Text] [Related]
7. IL-16 represses HIV-1 promoter activity.
Maciaszek JW; Parada NA; Cruikshank WW; Center DM; Kornfeld H; Viglianti GA
J Immunol; 1997 Jan; 158(1):5-8. PubMed ID: 8977168
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
Montaner LJ; Griffin P; Gordon S
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis.
Li Z; Xiong Y; Peng Y; Pan J; Chen Y; Wu X; Hussain S; Tien P; Guo D
FEBS Lett; 2005 Jun; 579(14):3100-6. PubMed ID: 15913611
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors block HIV-1 replication by affecting both cellular and viral targets.
Yu L; Mohanram V; Simonson OE; Smith CI; Spetz AL; Mohamed AJ
Biochem Biophys Res Commun; 2009 Jul; 385(1):100-5. PubMed ID: 19426715
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages.
Liou LY; Herrmann CH; Rice AP
J Virol; 2004 Aug; 78(15):8114-9. PubMed ID: 15254183
[TBL] [Abstract][Full Text] [Related]
12. Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs.
Yu W; Wang Y; Shaw CA; Qin XF; Rice AP
Retrovirology; 2006 Jun; 3():32. PubMed ID: 16764723
[TBL] [Abstract][Full Text] [Related]
13. Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription.
Urano E; Shimizu S; Futahashi Y; Hamatake M; Morikawa Y; Takahashi N; Fukazawa H; Yamamoto N; Komano J
AIDS; 2008 May; 22(9):1081-3. PubMed ID: 18520353
[TBL] [Abstract][Full Text] [Related]
14. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1.
Sung TL; Rice AP
PLoS Pathog; 2009 Jan; 5(1):e1000263. PubMed ID: 19148268
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 in the developing CNS: developmental differences in gene expression.
Buzy JM; Lindstrom LM; Zink MC; Clements JE
Virology; 1995 Jul; 210(2):361-71. PubMed ID: 7618273
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression.
Naif HM; Chang J; Ho-Shon M; Li S; Cunningham AL
AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1237-45. PubMed ID: 8870845
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages.
Rice AP; Herrmann CH
Curr HIV Res; 2003 Oct; 1(4):395-404. PubMed ID: 15049426
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
19. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
20. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication.
Hiebenthal-Millow K; Kirchhoff F
Virology; 2002 Jan; 292(1):169-75. PubMed ID: 11878920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
